Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

The challenge of soft tissue sarcomas—critical aspects of therapies with curative intent

The challenge of soft tissue sarcomas—critical aspects of therapies with curative intent editorial memo (2014) 7:125 DOI 10.1007/s12254-014-0162-8 The challenge of soft tissue sarcomas—critical aspects of therapies with curative intent Georg Pall Received: 1 July 2014 / Accepted: 14 July 2014 / Published online: 20 August 2014 © Springer-Verlag Wien 2014 Despite several advances, the treatment of soft tissue improve local control in the treatment of soft tissue sar- sarcomas can still be regarded as a clinical challenge. comas. Within his article, he also provides us with a com- The main reasons for that are the paucity of random- prehensive review on the literature comparing IORT with ized phase III trials, the rareness of the disease and the conventional external beam radiotherapy that led to the requirement for a close interdisciplinary cooperation as acceptance of IORT as an important part of multimodal- to achieve optimal treatment results. As a consequence, ity treatment. in daily practice, many difficult-to-answer questions Third, Wöll E. [3] covers the concept of neoadjuvant che- arise during the treatment of these patients concerning motherapy. Due to the high rate of distant recurrences the different steps that have to be taken. seen in high-grade soft tissue sarcomas and the low effi- Alluding to that, in November 2013, we convened http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png memo - Magazine of European Medical Oncology Springer Journals

The challenge of soft tissue sarcomas—critical aspects of therapies with curative intent

The challenge of soft tissue sarcomas—critical aspects of therapies with curative intent

Abstract

editorial memo (2014) 7:125 DOI 10.1007/s12254-014-0162-8 The challenge of soft tissue sarcomas—critical aspects of therapies with curative intent Georg Pall Received: 1 July 2014 / Accepted: 14 July 2014 / Published online: 20 August 2014 © Springer-Verlag Wien 2014 Despite several advances, the treatment of soft tissue improve local control in the treatment of soft tissue sar- sarcomas can still be regarded as a clinical challenge. comas. Within his article, he also provides us...
Loading next page...
 
/lp/springer-journals/the-challenge-of-soft-tissue-sarcomas-critical-aspects-of-therapies-x2OCtK09Bh

References (5)

Publisher
Springer Journals
Copyright
Copyright © 2014 by Springer-Verlag Wien
Subject
Medicine & Public Health; Oncology; Medicine/Public Health, general
ISSN
1865-5041
eISSN
1865-5076
DOI
10.1007/s12254-014-0162-8
Publisher site
See Article on Publisher Site

Abstract

editorial memo (2014) 7:125 DOI 10.1007/s12254-014-0162-8 The challenge of soft tissue sarcomas—critical aspects of therapies with curative intent Georg Pall Received: 1 July 2014 / Accepted: 14 July 2014 / Published online: 20 August 2014 © Springer-Verlag Wien 2014 Despite several advances, the treatment of soft tissue improve local control in the treatment of soft tissue sar- sarcomas can still be regarded as a clinical challenge. comas. Within his article, he also provides us with a com- The main reasons for that are the paucity of random- prehensive review on the literature comparing IORT with ized phase III trials, the rareness of the disease and the conventional external beam radiotherapy that led to the requirement for a close interdisciplinary cooperation as acceptance of IORT as an important part of multimodal- to achieve optimal treatment results. As a consequence, ity treatment. in daily practice, many difficult-to-answer questions Third, Wöll E. [3] covers the concept of neoadjuvant che- arise during the treatment of these patients concerning motherapy. Due to the high rate of distant recurrences the different steps that have to be taken. seen in high-grade soft tissue sarcomas and the low effi- Alluding to that, in November 2013, we convened

Journal

memo - Magazine of European Medical OncologySpringer Journals

Published: Aug 20, 2014

There are no references for this article.